4.6 Article

The Use of Anchored Agonists of Phagocytic Receptors for Cancer Immunotherapy: B16-F10 Murine Melanoma Model

Related references

Note: Only part of the references are listed.
Review Immunology

C-type lectin receptor-induced NF-κB activation in innate immune and inflammatory responses

Lara M. Kingeter et al.

CELLULAR & MOLECULAR IMMUNOLOGY (2012)

News Item Biotechnology & Applied Microbiology

Anticancer TLR agonists on the ropes

Malini Guha

NATURE REVIEWS DRUG DISCOVERY (2012)

Review Cell Biology

Mechanisms of Fc Receptor and Dectin-1 Activation for Phagocytosis

Helen S. Goodridge et al.

TRAFFIC (2012)

Review Oncology

The role of innate immune signals in antitumor immunity

Masahisa Jinushi

ONCOIMMUNOLOGY (2012)

Article Biochemistry & Molecular Biology

In search of a novel target - Phosphatidylserine exposed by non-apoptotic tumor cells and metastases of malignancies with poor treatment efficacy

Sabrina Riedl et al.

BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2011)

Article Oncology

Novel innate cancer killing activity in humans

Michael J. Blanks et al.

CANCER CELL INTERNATIONAL (2011)

Review Oncology

Glucan-immunostimulant, adjuvant, potential drug

Vaclav Vetvicka

WORLD JOURNAL OF CLINICAL ONCOLOGY (2011)

Article Immunology

Resilience to Bacterial Infection: Difference between Species Could Be Due to Proteins in Serum

H. Shaw Warren et al.

JOURNAL OF INFECTIOUS DISEASES (2010)

Review Pharmacology & Pharmacy

Therapeutic anti-inflammatory potential of formyl-peptide receptor agonists

Neil Dufton et al.

PHARMACOLOGY & THERAPEUTICS (2010)

Review Immunology

C-type lectins and phagocytosis

Ann M. Kerrigan et al.

IMMUNOBIOLOGY (2009)

Review Immunology

Toll-like receptor agonists in cancer therapy

Sylvia Adams

IMMUNOTHERAPY (2009)

Review Oncology

The effects of β-glucan on human immune and cancer cells

Godfrey Chi-Fung Chan et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2009)

Article Oncology

Transforming growth factor-β and the immune response:: Implications for anticancer therapy

Stephen H. Wrzesinski et al.

CLINICAL CANCER RESEARCH (2007)

Review Biochemistry & Molecular Biology

Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists

Holger Kanzler et al.

NATURE MEDICINE (2007)

Article Multidisciplinary Sciences

Transferable anticancer innate immunity in spontaneous regression/complete resistance mice

Amy M. Hicks et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Article Oncology

Non-classical HLA-G antigen and its role in the cancer progression

P Tripathi et al.

CANCER INVESTIGATION (2006)

Article Immunology

A novel glyco-conjugate vaccine against fungal pathogens

A Torosantucci et al.

JOURNAL OF EXPERIMENTAL MEDICINE (2005)

Article Multidisciplinary Sciences

Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance

G Willimsky et al.

NATURE (2005)

Article Rheumatology

TLR2 modulates inflammation in zymosan-induced arthritis in mice

ME Frasnelli et al.

ARTHRITIS RESEARCH & THERAPY (2005)

Article Immunology

Integration of Toll-like receptor and phagocytic signaling for tailored immunity

DM Underhill et al.

MICROBES AND INFECTION (2004)

Article Multidisciplinary Sciences

Spontaneous regression of advanced cancer: Identification of a unique genetically determined, age-dependent trait in mice

Z Cui et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Review Immunology

Cancer immunoediting: from immunosurveillance to tumor escape

GP Dunn et al.

NATURE IMMUNOLOGY (2002)

Review Immunology

Receptors for chemotactic formyl peptides as pharmacological targets

YY Le et al.

INTERNATIONAL IMMUNOPHARMACOLOGY (2002)

Article Biochemistry & Molecular Biology

An extended conformation of the macrophage mannose receptor

CE Napper et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2001)